StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CNBX Pharmaceuticals's price to sales ratio was 7.1× on Mar 31, 2025, against 0.9× a year earlier. Over the last 2 years it ranged from 0.0× to 163.7×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Mar 31, 20257.1×+5.3
2024Dec 31, 20241.8×+1.0
2023Dec 29, 20230.8×−76.1
2022Dec 30, 202276.9×–

More CNBX Pharmaceuticals figures

See a number that looks wrong?